Novartis AG Statistics

Total Valuation

Novartis AG has a market cap or net worth of CHF 188.78 billion. The enterprise value is 209.44 billion.

Market Cap	188.78B
Enterprise Value	209.44B

Important Dates

The last earnings date was Thursday, July 17, 2025.

Earnings Date	Jul 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-3.37%
Shares Change (QoQ)	-0.96%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	1.84B

Valuation Ratios

The trailing PE ratio is 17.39 and the forward PE ratio is 14.21.

PE Ratio	17.39
Forward PE	14.21
PS Ratio	4.30
PB Ratio	5.64
P/TBV Ratio	n/a
P/FCF Ratio	12.28
P/OCF Ratio	11.42
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.06, with an EV/FCF ratio of 13.63.

EV / Earnings	19.29
EV / Sales	4.77
EV / EBITDA	11.06
EV / EBIT	13.74
EV / FCF	13.63

Financial Position

The company has a current ratio of 0.82, with a Debt / Equity ratio of 0.78.

Current Ratio	0.82
Quick Ratio	0.50
Debt / Equity	0.78
Debt / EBITDA	1.37
Debt / FCF	1.69
Interest Coverage	17.47

Financial Efficiency

Return on equity (ROE) is 32.49% and return on invested capital (ROIC) is 16.47%.

Return on Equity (ROE)	32.49%
Return on Assets (ROA)	11.88%
Return on Invested Capital (ROIC)	16.47%
Return on Capital Employed (ROCE)	26.39%
Revenue Per Employee	578,368
Profits Per Employee	143,099
Employee Count	75,883
Asset Turnover	0.55
Inventory Turnover	2.17

Taxes

In the past 12 months, Novartis AG has paid 1.57 billion in taxes.

Income Tax	1.57B
Effective Tax Rate	12.62%

Stock Price Statistics

The stock price has decreased by -1.27% in the last 52 weeks. The beta is 0.49, so Novartis AG's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	-1.27%
50-Day Moving Average	95.63
200-Day Moving Average	94.04
Relative Strength Index (RSI)	61.77
Average Volume (20 Days)	346,061

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Novartis AG had revenue of CHF 43.89 billion and earned 10.86 billion in profits. Earnings per share was 5.45.

Revenue	43.89B
Gross Profit	33.48B
Operating Income	15.25B
Pretax Income	12.41B
Net Income	10.86B
EBITDA	18.73B
EBIT	15.25B
Earnings Per Share (EPS)	5.45

Full Income Statement

Balance Sheet

The company has 5.35 billion in cash and 25.96 billion in debt, giving a net cash position of -20.60 billion.

Cash & Cash Equivalents	5.35B
Total Debt	25.96B
Net Cash	-20.60B
Net Cash Per Share	n/a
Equity (Book Value)	33.44B
Book Value Per Share	17.25
Working Capital	-4.59B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.53 billion and capital expenditures -1.16 billion, giving a free cash flow of 15.37 billion.

Operating Cash Flow	16.53B
Capital Expenditures	-1.16B
Free Cash Flow	15.37B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.28%, with operating and profit margins of 34.76% and 24.74%.

Gross Margin	76.28%
Operating Margin	34.76%
Pretax Margin	28.28%
Profit Margin	24.74%
EBITDA Margin	42.68%
EBIT Margin	34.76%
FCF Margin	35.02%

Dividends & Yields

Novartis AG does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	57.26%
Buyback Yield	3.37%
Shareholder Yield	n/a
Earnings Yield	5.75%
FCF Yield	8.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Novartis AG has an Altman Z-Score of 3.73 and a Piotroski F-Score of 6.

Altman Z-Score	3.73
Piotroski F-Score	6